reased platelet cell count hair loss. Paclitaxel is obtained from Taxus media. The chemical name for paclitaxel is. β,Epoxy,2a,4,7β,10ß,13a hexahydroxytaxenone 4,diacetatebenzoate ester with (2R,3S) N-benzoylphenylisoserine See Product Monograph for complete product informationINDICATIONS. uted ABRAXANE suspension from the vial(s) into a syringe. tiredness Abbreviated Package Insert. Appropriate management of therapy and ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) is an antimicrotubule agent that promotes the assembly of microtubules The most common serious adverse reactions of ABRAXANE in combination with carboplatin for non-small cell lung cancer are anemia (4%) and pneumonia (3%). ABRAXANE is a microtubule inhibitor indicated for the treatment of: Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse ABRAXANE is a prescription medicine used to treat: advanced breast cancer in people who have already received certain other medicines for their cancer. The most common adverse reactions resulting in permanent discontinuation of ABRAXANE are neutropenia (3%), thrombocytopenia (3%), and peripheral neuropathy (1%) The most common side effects of ABRAXANE in people with non-small cell lung cancer include: low red blood cell count (anemia) reased white blood cell count. numbness, tingling, pain, or weakness in the hands or feet nausea. See Product Monograph for complete product informationINDICATIONS ABRAXANE ® for Injectable Suspension (paclitaxel powder for injectable ABRAXANE should be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents. ABRAXANE ® for Injectable Suspension (paclitaxel powder for injectable suspension) (nanoparticle, albumin-bound [nab ®] paclitaxel) is indicated for: the treatment of metastatic breast cancer atient: Dosing volume (mL) = Total dose (mg)/5 (mg/mL).Slowly withdraw the dosing volume of the reconst. advanced non Abbreviated Package Insert. Inject the appropriate amount of reconstituted ABRAXANE into an empty, sterile, intravenous infusion bag (plasticized polyviny The active agent in ABRAXANE is paclitaxel, a natural product with antitumor activity.
reased platelet cell count hair loss. Paclitaxel is obtained from Taxus media. The chemical name for paclitaxel is. β,Epoxy,2a,4,7β,10ß,13a hexahydroxytaxenone 4,diacetatebenzoate ester with (2R,3S) N-benzoylphenylisoserine See Product Monograph for complete product informationINDICATIONS. uted ABRAXANE suspension from the vial(s) into a syringe. tiredness Abbreviated Package Insert. Appropriate management of therapy and ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) is an antimicrotubule agent that promotes the assembly of microtubules The most common serious adverse reactions of ABRAXANE in combination with carboplatin for non-small cell lung cancer are anemia (4%) and pneumonia (3%). ABRAXANE is a microtubule inhibitor indicated for the treatment of: Metastatic breast cancer, after failure of combination chemotherapy for metastatic disease or relapse ABRAXANE is a prescription medicine used to treat: advanced breast cancer in people who have already received certain other medicines for their cancer. The most common adverse reactions resulting in permanent discontinuation of ABRAXANE are neutropenia (3%), thrombocytopenia (3%), and peripheral neuropathy (1%) The most common side effects of ABRAXANE in people with non-small cell lung cancer include: low red blood cell count (anemia) reased white blood cell count. numbness, tingling, pain, or weakness in the hands or feet nausea. See Product Monograph for complete product informationINDICATIONS ABRAXANE ® for Injectable Suspension (paclitaxel powder for injectable ABRAXANE should be administered under the supervision of a physician experienced in the use of cancer chemotherapeutic agents. ABRAXANE ® for Injectable Suspension (paclitaxel powder for injectable suspension) (nanoparticle, albumin-bound [nab ®] paclitaxel) is indicated for: the treatment of metastatic breast cancer atient: Dosing volume (mL) = Total dose (mg)/5 (mg/mL).Slowly withdraw the dosing volume of the reconst. advanced non Abbreviated Package Insert. Inject the appropriate amount of reconstituted ABRAXANE into an empty, sterile, intravenous infusion bag (plasticized polyviny The active agent in ABRAXANE is paclitaxel, a natural product with antitumor activity.
Français
English
Deutsch
Español
Italiano
Português